🔎 Trials Near Me

Domov › Psoriatični artritis › Ohio

Klinične študije za Psoriatični artritis v Ohio

14 študij za Psoriatični artritis išče udeležence na lokacijah v Ohio.

Mesta v Ohio

Uradno besedilo študije (angleško)

A Long-term Extension (LTE) Study of Guselkumab in Pediatric Participants

  • Cincinnati Children's Hospital Medical Center, Cincinnati
Vključevanje udeležencevFaza 3
Starost 3 in več · Vsi spoli · Posodobljeno 25. sep. 2026 · NCT06663332

A Study to Evaluate the Efficacy and Safety of JNJ-88545223 for the Treatment of Participants With Active Psoriatic Arthritis

  • Paramount Medical Research & Consulting, Middleburg Heights
Vključevanje udeležencevFaza 2
Starost 18 in več · Vsi spoli · Posodobljeno 25. sep. 2026 · NCT07321873

Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVO

  • Ohio State University Comprehensive Cancer Center, Columbus
Vključevanje udeležencevFaza 1
Starost 18 in več · Vsi spoli · Posodobljeno 23. sep. 2026 · NCT03816345

A Study of Zasocitinib in Adults With Psoriatic Arthritis Who Have Not Taken Biologic Medicines

  • University Hospitals | UH Cleveland Medical Center - Department of Medicine - Rheumatology Division, Cleveland
  • Paramount Medical Research & Consulting, LLC, Middleburg Heights
Vključevanje udeležencevFaza 3
Starost 18 in več · Vsi spoli · Posodobljeno 17. sep. 2026 · NCT06671483

Evaluation of Sonelokimab in Patients With Active Psoriatic Arthritis and Anti-TNFα Inadequate Response

  • Clinical Site, Middleburg Heights
Vključevanje udeležencevFaza 3
Starost 18 in več · Vsi spoli · Posodobljeno 11. sep. 2026 · NCT06641089

A Study of Zasocitinib in Adults With Psoriatic Arthritis Who Have or Have Not Been Treated With Biologic Medicines

  • University Hospitals | UH Cleveland Medical Center - Department of Medicine - Rheumatology Division, Cleveland
  • Paramount Medical Research & Consulting, LLC, Middleburg Heights
Vključevanje udeležencevFaza 3
Starost 18 in več · Vsi spoli · Posodobljeno 9. sep. 2026 · NCT06671496

Continuation Study of Zasocitinib in Adults With Psoriatic Arthritis

  • Paramount Medical Research & Consulting, LLC, Middleburg Heights
Vključevanje udeležencevFaza 3
Starost 18 in več · Vsi spoli · Posodobljeno 9. sep. 2026 · NCT07286058

A Study to Assess Adverse Events, Change in Disease Activity, and How the Drug Moves Through the Body in Children With Juvenile Psoriatic Arthritis (jPsA) Receiving Subcutaneously Injected Risankizumab or Adalimumab

  • MetroHealth Medical Center /ID# 262377, Cleveland
  • Cleveland Clinic - Cleveland /ID# 276655, Cleveland
Vključevanje udeležencevFaza 3
Starost 5–17 · Vsi spoli · Posodobljeno 1. sep. 2026 · NCT06100744

Observational Study of Pediatric Rheumatic Diseases: The CARRA Registry

  • Akron Children's Hospital, Akron
  • Cincinnati Children's Hospital Medical Center, Cincinnati
  • Metrohealth Medical Center, Cleveland
  • in še 2
Vključevanje udeležencevOpazovalna študija
Do 21 let · Vsi spoli · Posodobljeno 27. avg. 2026 · NCT02418442

A Study to Learn if Bimekizumab Given in Different Ways is Safe and Moves Similarly Throughout the Body Over Time in Adults

  • Pa0019 144, Vandalia
Vključevanje udeležencevFaza 1
Starost 18 in več · Vsi spoli · Posodobljeno 6. jul. 2026 · NCT07290036

A Study to Evaluate the Impact of Upadacitinib on Spondyloarthritis Outcomes in Patients With Active Psoriatic Arthritis

  • University Hospitals Cleveland Medical Center, Cleveland
Vključevanje udeležencevFaza 4
Starost 18 in več · Vsi spoli · Posodobljeno 3. apr. 2026 · NCT06454188

Study of Targeted Therapies for the Treatment of Adult Participants With Active Psoriatic Arthritis

  • Paramount Medical Research and Consulting /ID# 272757, Middleburg Heights
Vključevanje udeležencevFaza 2
Starost 18 in več · Vsi spoli · Posodobljeno 18. dec. 2025 · NCT06865105

Guselkumab vs Golimumab in PsA TNF Inadequate Responder Patients

  • Cincy Arthritis, Blue Ash
  • Southern Ohio Rheumatology, Wheelersburg
Vključevanje udeležencevFaza 3
Starost 18–80 · Vsi spoli · Posodobljeno 9. okt. 2025 · NCT05669833

IMPACT - AndHealth Autoimmune Research Registry

  • AndHealth, Columbus
Vključevanje udeležencevOpazovalna študija
Starost 18–70 · Vsi spoli · Posodobljeno 29. jun. 2023 · NCT05883371

Vir: ClinicalTrials.gov, podatki pridobljeni 5. okt. 2026. Vsaka študija ima svoje pogoje vključitve; ekipa študije odloči, kdo lahko sodeluje.